Integrated 18F-FDG PET/CT and perfusion CT of primary colorectal cancer: Effect of interand intraobserver agreement on metabolic-vascular parameters

American Journal of Roentgenology

Volumn 199, Issue 5, 2012, Pages 1003-1009

  Goh, Vicky ^a   Shastry, Manu ^b   Engledow, Alec ^b   Kozarski, Robert ^c   Peck, Jacqui ^b   Endozo, Raymondo ^b   Rodriguez Justo, Manuel ^b   Taylor, Stuart A ^b   Halligan, Steve ^b   Groves, Ashley M ^b  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY COLLEGE HOSPITAL   (United Kingdom)

^c UNIVERSITY OF HERTFORDSHIRE   (United Kingdom)

Author keywords

Colorectal cancer; FDG PET; Perfusion CT; Radioisotopes

Indexed keywords

FLUORODEOXYGLUCOSE F 18; IOHEXOL;

AGED; ARTICLE; BLOOD VOLUME; CANCER STAGING; CLINICAL ARTICLE; COLORECTAL CARCINOMA; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; HEMATOLOGICAL PARAMETERS; HUMAN; INTERRATER RELIABILITY; INTRARATER RELIABILITY; MALE; METABOLISM; MULTIDETECTOR COMPUTED TOMOGRAPHY; PERMEABILITY SURFACE AREA PRODUCT; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROSPECTIVE STUDY; STANDARDIZED PERFUSION VALUE; TUMOR BLOOD FLOW; TUMOR METABOLISM; TUMOR VASCULARIZATION; TUMOR VOLUME;

ADENOCARCINOMA; AGED; COLORECTAL NEOPLASMS; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; OBSERVER VARIATION; POSITRON-EMISSION TOMOGRAPHY AND COMPUTED TOMOGRAPHY; RADIOPHARMACEUTICALS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84868026584     PISSN: 0361803X     EISSN: 15463141     Source Type: Journal    
DOI: 10.2214/AJR.11.7823     Document Type: Article

References (36)

1. 18F]fluorodeoxyglucose positron emission tomography imaging. Clin Cancer Res 2004;10:2245-2252 (Pubitemid 38445681)
2. Mankoff DA, Dunnwald LK, Gralow JR, et al. Changes in blood flow and metabolism in locally advanced breast cancer treated with neoadjuvant chemotherapy. J Nucl Med 2003;44:1806-1814 (Pubitemid 39663314)
3. Komar G, Kauhanen S, Liukko K, et al. Decreased blood flow with increased metabolic activity: a novel sign of pancreatic tumor aggressiveness. Clin Cancer Res 2009;15:5511-5517
4. Dunnwald LK, Gralow JR, Ellis GK, et al. Tumor metabolism and blood flow changes by positron emission tomography: relation to survival in patients treated with neoadjuvant chemotherapy for locally advanced breast cancer. J Clin Oncol 2008;26:4449-4457
5. 18FFDG kinetics in locally advanced breast cancer: correlation with tumor blood flow and changes in response to neoadjuvant chemotherapy. J Nucl Med 2004;45:1829-1837 (Pubitemid 47618439)
6. Miles KA, Williams RE. Warburg revisited: imaging tumour blood flow and metabolism. Cancer Imaging 2008;8:81-86 (Pubitemid 351517291)
7. Padhani AR, Miles KA. Multiparametric imaging of tumor response to therapy. Radiology 2010;256:348-364
8. Miles KA, Griffiths MR, Keith CJ. Blood flowmetabolic relationships are dependent on tumour size in non-small cell lung cancer: a study using quantitative contrast-enhanced computer tomography and positron emission tomography. Eur J Nucl Med Mol Imaging 2006;33:22-28 (Pubitemid 41785305)
9. Tateishi U, Nishihara H, Tsukamoto E, Morikawa T, Tamaki N, Miyasaka K. Lung tumors evaluated with FDG-PET and dynamic CT: the relationship between vascular density and glucose metabolism. J Comput Assist Tomogr 2002;26:185-190 (Pubitemid 34233362)
10. Groves AM, Wishart GC, Shastry M, et al. Metabolicflow relationships in primary breast cancer: feasibility of combined PET/dynamic contrastenhanced CT. Eur J Nucl Med Mol Imaging 2009;36:416-421
11. Semple SI, Gilbert FJ, Redpath TW, et al. The relationship between vascular and metabolic characteristics of primary breast tumours. Eur Radiol 2004;14:2038-2045 (Pubitemid 39481174)
12. Bisdas S, Spicer K, Rumboldt Z. Whole-tumor perfusion CT parameters and glucose metabolism measurements in head and neck squamous cell carcinomas: a pilot study using combined positronemission tomography/CT imaging. AJNR 2008;29:1376-1381
13. Hirasawa S, Tsushima Y, Takei H, et al. Inverse correlation between tumor perfusion and glucose uptake in human head and neck tumors. Acad Radiol 2007;14:312-318 (Pubitemid 46329457)
14. Veit-Haibach P, Treyer V, Strobel K, et al. Feasibility of integrated CT-liver perfusion in routine FDG-PET/CT. Abdom Imaging 2010;35:528-536
15. 18F-FDG PET/perfusion CT with histopathologic correlation. J Nucl Med 2012;53:687-692
16. Goh V, Rodriguez-Justo M, Engledow A, et al. Assessment of the metabolic-flow phenotype of primary colorectal cancer: correlations with microvessel density are influenced by the histological scoring method. Eur Radiol 2012 [Epub ahead of print]
17. Goh V, Shastry M, Engledow A, et al. Commercial software upgrades may significantly alter perfusion CT parameter values in colorectal cancer. Eur Radiol 2011;21:744-749
18. ImPACT. CT patient dosimetry calculator, version 1.0.3. ImPACT Website. www.impactscan.org/ctdosimetry.htm. Accessed June 26, 2012
19. St. Lawrence KS, Lee TY. An adiabatic approximation to the tissue homogeneity model for water exchange in the brain. Part I. Theoretical derivation. J Cereb Blood Flow Metab 1998;18:1365-1377 (Pubitemid 28559684)
20. Miles KA, Griffiths MR, Fuentes MA. Standardized perfusion value: universal CT contrast enhancement scale that correlates with FDG PET in lung nodules. Radiology 2001;220:548-553 (Pubitemid 32667201)
21. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986;327:307-310 (Pubitemid 16134762)
22. Purdie TG, Henderson E, Lee TY. Functional CT imaging of angiogenesis in rabbit VX2 soft-tissue tumour. Phys Med Biol 2001;46:3161-3175 (Pubitemid 34568065)
23. Ng CS, Kodama Y, Mullani NA, et al. Tumor blood flow measured by perfusion computed tomography and 15O-labeled water positron emission tomography: a comparison study. J Comput Assist Tomogr 2009;33:460-465
24. Marom EM, Munden RF, Truong MT, et al. Interobserver and intraobserver variability of standardized uptake value measurements in nonsmallcell carcinoma lung cancer. J Thorac Imaging 2006;21:205-212 (Pubitemid 44258947)
25. 18F-FDG PET and CT measurements of tumor response to therapy. J Nucl Med 2009;50:1760-1769
26. 18F-FDG PET/CT in patients with sarcomas: interobserver variability of quantitative parameters in treatment-induced changes in histopathologically responding and nonresponding tumors. J Nucl Med 2008;49:1038-1046 (Pubitemid 351948010)
27. Weber WA, Ziegler SI, Thödtmann R, Hanauske AR, Schwaiger M. Reproducibility of metabolic measurements in malignant tumors using FDG PET. J Nucl Med 1999;40:1771-1777 (Pubitemid 29523568)
28. Minn H, Zasadny KR, Quint LE, Wahl RL. Lung cancer: reproducibility of quantitative measurements for evaluating 2-[F-18]-fluoro-2-deoxy-D-glucose uptake at PET. Radiology 1995;196:167-173
29. 18F-FDG PET in malignant tumors. J Nucl Med 2008;49:1804-1808
30. 18F]fluoro-D-glucose. Mol Imaging Biol 2002;4:171-178 (Pubitemid 34272701)
31. De Langen AJ, Lubberink M, Boellard R, et al. Reproducibility of tumor perfusion measurements using 15O-labeled water PET. J Nucl Med 2008;49:1763-1768
32. Huang YE, Chen CF, Huang YJ, Konda SD, Appelbaum DE, Pu Y. Interobserver variability among measurements of the maximum and mean standardized uptake values on (18) F-FDG PET/CT and measurements of tumor size on diagnostic CT in patients with pulmonary tumors. Acta Radiol 2010;51:782-788
33. Bisdas S, Surlan-Popovic K, Didanovic V, Vogl TJ. Functional CT of squamous cell carcinoma in the head and neck: repeatability of tumor and muscle quantitative measurements, inter and intraobserver agreement. Eur Radiol 2008;18:2241-2250
34. Goh V, Halligan S, Hugill JA, Bartram CI. Quantitative colorectal perfusion measurement using MDCT: comparison of colorectal cancer and skeletal muscle reproducibility. AJR 2006;187:164-169 (Pubitemid 46100163)
35. Goh V, Halligan S, Hugill JA, Bassett P, Bartram CI. Quantitative colorectal cancer perfusion measurements using MDCT: inter and intra-observer agreement. AJR 2005;185:225-231
36. Goh V, Halligan S, Gharpuray A, Wellsted D, Sundin J, Bartram CI. Quantitative assessment of tumor vascular parameters using MDCT: influence of the tumor region of interest (ROI). Radiology 2008;247:726-732